<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-789
Date of Submission: 2025-04-06

This report was submitted by a Physician from Skinner, Franklin and Hayes Medical Center concerning patient ANON-PX-2941. The subject is a 32-year-old other with a significant medical history including coronary artery disease, atrial fibrillation, anxiety. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin administered via the Oral route at a dosage of 385mg, initiated on 2025-03-29 for Neuropathic pain and discontinued on 2025-04-02; Levothyroxine administered via the Intravenous route at a dosage of 330mg, initiated on 2025-03-29 for Hypothyroidism and discontinued on 2025-04-02.

On approximately 2025-03-31, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Anaphylaxis, Dizziness, Nausea. The Anaphylaxis was classified as Severe in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Not Recovered'. The Dizziness was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. The Nausea was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive rechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Whole imagine young large. Great few make very side. Five beyond choose them.</data>
report_id: ADR-2025-789
report_date: '2025-04-06'
patient_details:
  patient_id: ANON-PX-2941
  gender: Other
  relevant_history:
  - coronary artery disease
  - atrial fibrillation
  - anxiety
  age_at_reaction: 32
suspected_drugs:
- drug_name: Gabapentin
  dosage: 385mg
  route_of_administration: Oral
  start_date: '2025-03-29'
  indication_for_use: Neuropathic pain
  end_date: '2025-04-02'
- drug_name: Levothyroxine
  dosage: 330mg
  route_of_administration: Intravenous
  start_date: '2025-03-29'
  indication_for_use: Hypothyroidism
  end_date: '2025-04-02'
adverse_reactions:
- symptom_name: Anaphylaxis
  onset_date: '2025-03-31'
  severity: Severe
  outcome: Not Recovered
  intervention_required: true
- symptom_name: Dizziness
  onset_date: '2025-03-31'
  severity: Life-threatening
  outcome: Recovering
  intervention_required: false
- symptom_name: Nausea
  onset_date: '2025-03-31'
  severity: Moderate
  outcome: Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive rechallenge
reporting_facility: Skinner, Franklin and Hayes Medical Center
reporter_type: Physician
notes: Whole imagine young large. Great few make very side. Five beyond choose them.
